Checkmate Pharmaceuticals, Inc.: retained_earnings

Value{"amount": -217343000, "concept": "us-gaap:RetainedEarningsAccumulatedDeficit", "currency": "USD"}
Period (as of 2022-03-31)
Statuscurrent
EntityCheckmate Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-22-148774 · Open the official SEC filing →
Retrieved: 2026-08-19T17:00:28.648796+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001651431/retained-earnings/2022-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/29389564-cb61-47fa-94cf-6de416fdcaa5

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies